PEG10 directly regulated by E2Fs might have a role in the development of hepatocellular carcinoma

FEBS Letters

Volumn 582, Issue 18, 2008, Pages 2793-2798

  Wang, Chaochen ^a   Xiao, Ying ^b   Hu, Zhonghua ^a   Chen, Yibin ^a   Liu, Na ^a   Hu, Gengxi ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Apoptosis; E2F; Hepatocelluar carcinoma; PEG10

Indexed keywords

ANTINEOPLASTIC AGENT; MACROGOL; POLYETHYLENE GLYCOL 10; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR E2F4;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GENETICS; CLINICAL ARTICLE; DISEASE COURSE; EPIGENETICS; FEMALE; GENE EXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL LINE, TUMOR; E2F TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; GENOMIC IMPRINTING; HUMANS; LIVER NEOPLASMS; PROMOTER REGIONS (GENETICS); PROTEINS; UP-REGULATION;

EID: 47849109305     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2008.07.009     Document Type: Article

References (25)

1. Ono R., Kobayashi S., Wagatsuma H., Aisaka K., Kohda T., Kaneko-Ishino T., and Ishino F. A retrotransposon-derived gene, PEG10, is a novel imprinted gene located on human chromosome 7q21. Genomics 73 (2001) 232-237
2. Clark M.B., Janicke M., Gottesbuhren U., Kleffmann T., Legge M., Poole E.S., and Tate W.P. Mammalian gene PEG10 expresses two reading frames by high efficiency -1 frameshifting in embryonic-associated tissues. J. Biol. Chem. 282 (2007) 37359-37369
3. Jia H.L., et al. Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma. Clin. Cancer Res. 13 (2007) 1133-1139
4. Ip W.K., Lai P.B., Wong N.L., Sy S.M., Beheshti B., Squire J.A., and Wong N. Identification of PEG10 as a progression related biomarker for hepatocellular carcinoma. Cancer Lett. 250 (2007) 284-291
5. Tsou A.P., Chuang Y.C., Su J.Y., Yang C.W., Liao Y.L., Liu W.K., Chiu J.H., and Chou C.K. Overexpression of a novel imprinted gene, PEG10, in human hepatocellular carcinoma and in regenerating mouse livers. J. Biomed. Sci. 10 (2003) 625-635
6. Luo J.H., et al. Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology 44 (2006) 1012-1024
7. Okabe H., Satoh S., Furukawa Y., Kato T., Hasegawa S., Nakajima Y., Yamaoka Y., and Nakamura Y. Involvement of PEG10 in human hepatocellular carcinogenesis through interaction with SIAH1. Cancer Res. 63 (2003) 3043-3048
8. Jie X., et al. Androgen activates PEG10 to promote carcinogenesis in hepatic cancer cells. Oncogene 26 (2007) 5741-5751
9. Li C.M., et al. PEG10 is a c-MYC target gene in cancer cells. Cancer Res. 66 (2006) 665-672
10. Trimarchi J.M., and Lees J.A. Sibling rivalry in the E2F family. Nat. Rev. Mol. Cell Biol. 3 (2002) 11-20
11. Stevaux O., and Dyson N.J. A revised picture of the E2F transcriptional network and RB function. Curr. Opin. Cell Biol. 14 (2002) 684-691
12. Nevins J.R. The Rb/E2F pathway and cancer. Hum. Mol. Genet. 10 (2001) 699-703
13. Uhlen M., et al. A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol. Cell Proteomics 4 (2005) 1920-1932
14. Park Y.M., Choi J.Y., Bae S.H., Byun B.H., Ahn B.M., Kim B.S., and Shin D.Y. Microsatellite instability and mutations of E2F-4 in hepatocellular carcinoma from Korea. Hepatol. Res. 17 (2000) 102-111
15. Ye XZ D.Z. The ultramicrostructure of adult hepatic cells continuous cultured in vitro. Acta Biol. Ex. Sinical. 13 (1980) 361
16. Yang G., Xu Y., Chen X., and Hu G. IFITM1 plays an essential role in the antiproliferative action of interferon-gamma. Oncogene 26 (2007) 594-603
17. Huang R., Xing Z., Luan Z., Wu T., Wu X., and Hu G. A specific splicing variant of SVH, a novel human armadillo repeat protein, is up-regulated in hepatocellular carcinomas. Cancer Res. 63 (2003) 3775-3782
18. Leng X., Noble M., Adams P.D., Qin J., and Harper J.W. Reversal of growth suppression by p107 via direct phosphorylation by cyclin D1/cyclin-dependent kinase 4. Mol. Cell. Biol. 22 (2002) 2242-2254
19. Li J.M., Hu P.P., Shen X., Yu Y., and Wang X.F. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites. Proc. Natl. Acad. Sci. USA 94 (1997) 4948-4953
20. Muller H., et al. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev. 15 (2001) 267-285
21. Semizarov D., Kroeger P., and Fesik S. siRNA-mediated gene silencing: a global genome view. Nucleic Acids Res. 32 (2004) 3836-3845
22. DeGregori J., and Johnson D.G. Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis. Curr. Mol. Med. 6 (2006) 739-748
23. DeGregori J., Leone G., Miron A., Jakoi L., and Nevins J.R. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci. USA 94 (1997) 7245-7250
24. Lux A., et al. Human retroviral gag- and gag-pol-like proteins interact with the transforming growth factor-beta receptor activin receptor-like kinase 1. J. Biol. Chem. 280 (2005) 8482-8493
25. Feinberg A.P., and Tycko B. The history of cancer epigenetics. Nat. Rev. Cancer 4 (2004) 143-153